跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,678 条关于
“CD20+”
全部
1,678
临床试验
909
药物
438
机构
1
资讯
330
去年
CD20 Bispecific Antibodies Show Promise in Lymphoma Treatment at ASH
去年
Rituxan Approved in Japan for Pediatric Chronic ITP
去年
Zamto-cel Shows Promise in Relapsed/Refractory DLBCL with Tandem CD20/CD19 Targeting
去年
Shark-Derived VNARs Show Promise in Targeting CD20 for Lymphoma Therapy
5年前
Bispecific CAR-T Therapy Targeting CD19/CD20 Shows Promise in Relapsed B-Cell Lymphoma
3年前
Bispecific CD20/CD19 CAR T-Cell Therapy Shows Promising Results in Mantle Cell Lymphoma
去年
Phase 4 Trial Explores Ozanimod Switch for Stable MS Patients on Anti-CD20 Therapy
3个月前
Everest Medicines Secures Asia-Pacific Rights to Bejescin, the First CD20 Antibody Approved for NMOSD
4个月前
ACROBiosystems and SeromYx Systems Partner to Advance Anti-CD20 Monoclonal Antibody Research Through Comprehensive Functional Profiling
去年
Genetic Factors Drive Early B Cell Repletion After Anti-CD20 Therapy in African American MS Patients
第 1 页,共 33 页
上一页
下一页